Vascular News and Research

RSS

Study to examine SYMPLICITY renal denervation system for treatment-resistant hypertension

The University of Michigan Cardiovascular Center will participate in a national clinical trial to treat the most challenging form of high blood pressure.

24 Sep 2012

Advanced optics system noninvasively maps out network of tiny blood vessels beneath the skin

The trained eye of a dermatologist can identify many types of skin lesions, but human sight only goes so far. Now an international team of researchers has developed an advanced optics system to noninvasively map out the network of tiny blood vessels beneath the outer layer of patients' skin, potentially revealing telltale signs of disease.

24 Sep 2012

Low levels of vitamin D associated with higher risk of heart attack and early death

New research from the University of Copenhagen and Copenhagen University Hospital shows that low levels of vitamin D are associated with a markedly higher risk of heart attack and early death. The study involved more than 10,000 Danes and has been published in the well-reputed American journal Arteriosclerosis, Thrombosis and Vascular Biology.

24 Sep 2012

Ziehm Imaging offers OR tables from Stille for vascular surgery

Effective immediately, Ziehm Imaging, the market and innovation leader for mobile C-arms, is offering OR tables from the Swedish manufacturer Stille to complement its Ziehm Vision RFD Hybrid Edition.

24 Sep 2012

Boehringer Ingelheim completes enrollment in nintedanib Phase III trials for IPF

Boehringer Ingelheim is pleased to announce the last patients have been randomised into the Phase III sister trials assessing the efficacy and safety of nintedanib (150 mg twice daily) in patients with idiopathic pulmonary fibrosis (IPF).

24 Sep 2012

Thomson Reuters names Sanford-Burnham cancer researcher among 2012 Citation Laureates

Thomson Reuters has selected Erkki Ruoslahti, M.D., Ph.D., cancer researcher and distinguished professor at Sanford-Burnham Medical Research Institute (Sanford-Burnham), as one of its 2012 Citation Laureates. Citation Laureates are scientists that Thomson Reuters has predicted to win the Nobel Prize.

24 Sep 2012

Routine tests flag up cancer danger in cryptogenic stroke

Blood tests and imaging findings could point to hidden malignancies in patients with cryptogenic stroke, say researchers.

21 Sep 2012

Routine tests flag up cancer danger in cryptogenic stroke

Blood tests and imaging findings could point to hidden malignancies in patients with cryptogenic stroke, say researchers.

21 Sep 2012

Intraoperative angiography ‘valuable’ in vascular brain surgery

Use of intraoperative angiography often leads to surgical revision during treatment of brain vascular abnormalities, say researchers.

21 Sep 2012

Case Western Reserve researcher to identify mechanistic link between psoriasis and CVD

Armed with a new $1.8 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, dermatology researcher Nicole Ward, PhD, assistant professor of dermatology and neurosciences at Case Western Reserve School of Medicine, will lead a study examining the link between psoriasis and heart attack and stroke.

21 Sep 2012

Children with mild to moderate kidney disease have carotid atherosclerosis

A federally funded study led by researchers at Johns Hopkins Children's Center has found that children with mild to moderate kidney disease have abnormally thick neck arteries, a condition known as carotid atherosclerosis, usually seen in older adults with a long history of elevated cholesterol and untreated hypertension.

21 Sep 2012

MU endocrinologist to receive American Heart Association lifetime achievement award

One of the first researchers to study the deadly link between cardiovascular disease and diabetes will receive an American Heart Association lifetime achievement award today at a ceremony in Washington, D.C. The award presented to University of Missouri endocrinologist James Sowers, MD, recognizes his more than 30 years of accomplishments as a physician, scientist and educator.

21 Sep 2012

Isolating and concentrating cells from whole blood: an interview with Victor Ugaz

There are several reasons for this. One is because analysis involving different kinds of blood cells may require you to be able to separate red blood cells from white blood cells, or plasma from whole blood etc.

21 Sep 2012

Cytochroma commences CTAP101 phase 3 study in secondary hyperparathyroidism

Cytochroma today announced the initiation of a phase 3 study of CTAP101 capsules in patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

21 Sep 2012

GSK3 inhibition protects against gum disease

Treatment with the cell-permeable glycogen synthase kinase -3β-specific enzyme inhibitor SB216763 successfully suppresses alveolar bone loss in mice infected with the main periodontal pathogen, Porphyromonas gingivalis, report researchers.

20 Sep 2012

PCA inhibits multiple pathways involved in development of diabetic nephropathy

Diabetic nephropathy is one of the most serious complications related to diabetes, often leading to end-stage kidney disease. Purple corn grown in Peru and Chile is a relative of blue corn, which is readily available in the U.S.

20 Sep 2012

Endothelial colony-forming cells show promise against inflammatory bowel disease

New research shows that a special population of stem cells found in cord blood has the innate ability to migrate to the intestine and contribute to the cell population there, suggesting the cells' potential to treat inflammatory bowel disease (IBD).

20 Sep 2012

New 24/7 Cardiologist program now available at ProMedica Toledo Hospital

ProMedica Toledo Hospital is the only hospital in northwest Ohio with a cardiologist on duty 24 hours a day, seven days a week, to treat patients who may be experiencing a heart attack.

20 Sep 2012

Aerpio Therapeutics commences AKB-9778 Phase 1b/2a trial in diabetic macular edema

Aerpio Therapeutics, a clinical-stage biopharmaceutical company developing innovative therapies for vascular diseases by targeting the Tie2 pathway, today announced that it has dosed the first patient in a Phase 1b/2a trial of AKB-9778 for the treatment of diabetic macular edema (DME).

20 Sep 2012

FDA clears Aptus’ HeliFX Aortic Securement System

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its thoracic-length HeliFX Aortic Securement System.

From Medtronic 19 Sep 2012

Vascular News and Research

Study to examine SYMPLICITY renal denervation system for treatment-resistant hypertension

Advanced optics system noninvasively maps out network of tiny blood vessels beneath the skin

Low levels of vitamin D associated with higher risk of heart attack and early death

Ziehm Imaging offers OR tables from Stille for vascular surgery

Boehringer Ingelheim completes enrollment in nintedanib Phase III trials for IPF

Thomson Reuters names Sanford-Burnham cancer researcher among 2012 Citation Laureates

Routine tests flag up cancer danger in cryptogenic stroke

Routine tests flag up cancer danger in cryptogenic stroke

Intraoperative angiography ‘valuable’ in vascular brain surgery

Case Western Reserve researcher to identify mechanistic link between psoriasis and CVD

Children with mild to moderate kidney disease have carotid atherosclerosis

MU endocrinologist to receive American Heart Association lifetime achievement award

Isolating and concentrating cells from whole blood: an interview with Victor Ugaz

Cytochroma commences CTAP101 phase 3 study in secondary hyperparathyroidism

GSK3 inhibition protects against gum disease

PCA inhibits multiple pathways involved in development of diabetic nephropathy

Endothelial colony-forming cells show promise against inflammatory bowel disease

New 24/7 Cardiologist program now available at ProMedica Toledo Hospital

Aerpio Therapeutics commences AKB-9778 Phase 1b/2a trial in diabetic macular edema

FDA clears Aptus’ HeliFX Aortic Securement System

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News